Morgenlander, William R. http://orcid.org/0000-0001-7205-3732
Chia, Wan Ni http://orcid.org/0000-0001-7287-694X
Parra, Beatriz
Monaco, Daniel R.
Ragan, Izabela
Pardo, Carlos A. http://orcid.org/0000-0002-4128-5335
Bowen, Richard
Zhong, Diana http://orcid.org/0000-0001-7487-7698
Norris, Douglas E. http://orcid.org/0000-0002-4631-2777
Ruczinski, Ingo
Durbin, Anna http://orcid.org/0000-0002-6652-2851
Wang, Lin-Fa http://orcid.org/0000-0003-2752-0535
Larman, H. Benjamin http://orcid.org/0000-0001-7863-196X
Robinson, Matthew L. http://orcid.org/0000-0003-0376-8560
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 NS110122, R01 GM136724, T32 AI007291)
MOH | National Medical Research Council (OFLCG19May-0034)
U.S. Department of State (Fulbright Visiting Research Scholarship)
Article History
Received: 5 October 2023
Accepted: 6 June 2024
First Online: 11 July 2024
Competing interests
: H.B.L. is an inventor on an issued patent (US20160320406A) filed by Brigham and Women’s Hospital that covers the use of the VirScan technology, and is a founder of Infinity Bio, Portal Bioscience and Alchemab. The remaining authors declare no competing interests.